![](/img/cover-not-exists.png)
940TiPA PHASE III TRIAL OF POSTOPERATIVE CHEMOTHERAPY OR NO FURTHER TREATMENT FOR PATIENTS WITH NODE- NEGATIVE STAGE I-II INTERMEDIATE OR HIGH RISK ENDOMETRIAL CANCER. ENGOT-EN2-DGCG / EORTC 55102
Amant, F., Lundgren, C., Kridelka, F., Ferrero, A., Greggi, S., Soliman, P.T., Mirza, M.R.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu338.64
Date:
September, 2014
File:
PDF, 63 KB
2014